Literature DB >> 22367732

Terminal patients in Belgian nursing homes: a cost analysis.

Steven Simoens1, Betty Kutten, Emmanuel Keirse, Paul Vanden Berghe, Claire Beguin, Marianne Desmedt, Myriam Deveugele, Christian Léonard, Dominique Paulus, Johan Menten.   

Abstract

Policy makers and health care payers are concerned about the costs of treating terminal patients. This study was done to measure the costs of treating terminal patients during the final month of life in a sample of Belgian nursing homes from the health care payer perspective. Also, this study compares the costs of palliative care with those of usual care. This multicenter, retrospective cohort study enrolled terminal patients from a representative sample of nursing homes. Health care costs included fixed nursing home costs, medical fees, pharmacy charges, other charges, and eventual hospitalization costs. Data sources consisted of accountancy and invoice data. The analysis calculated costs per patient during the final month of life at 2007/2008 prices. Nineteen nursing homes participated in the study, generating a total of 181 patients. Total mean nursing home costs amounted to 3,243 € per patient during the final month of life. Total mean nursing home costs per patient of 3,822 € for patients receiving usual care were higher than costs of 2,456 € for patients receiving palliative care (p = 0.068). Higher costs of usual care were driven by higher hospitalization costs (p < 0.001). This study suggests that palliative care models in nursing homes need to be supported because such care models appear to be less expensive than usual care and because such care models are likely to better reflect the needs of terminal patients.

Entities:  

Mesh:

Year:  2012        PMID: 22367732     DOI: 10.1007/s10198-012-0384-9

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  10 in total

1.  A high-volume specialist palliative care unit and team may reduce in-hospital end-of-life care costs.

Authors:  Thomas J Smith; Patrick Coyne; Brian Cassel; Lynne Penberthy; Alison Hopson; Mary Ann Hager
Journal:  J Palliat Med       Date:  2003-10       Impact factor: 2.947

2.  Government expenditures at the end of life for short- and long-stay nursing home residents: differences by hospice enrollment status.

Authors:  Susan C Miller; Orna Intrator; Pedro Gozalo; Jason Roy; Janet Barber; Vincent Mor
Journal:  J Am Geriatr Soc       Date:  2004-08       Impact factor: 5.562

3.  Costs of terminal patients who receive palliative care or usual care in different hospital wards.

Authors:  Steven Simoens; Betty Kutten; Emmanuel Keirse; Paul Vanden Berghe; Claire Beguin; Marianne Desmedt; Myriam Deveugele; Christian Léonard; Dominique Paulus; Johan Menten
Journal:  J Palliat Med       Date:  2010-11-01       Impact factor: 2.947

4.  Resource consumption and costs of palliative care services in Spain: a multicenter prospective study.

Authors:  Xavier Gómez-Batiste; Albert Tuca; Esther Corrales; Josep Porta-Sales; Maria Amor; José Espinosa; Josep M A Borràs; Isabel de la Mata; Xavier Castellsagué
Journal:  J Pain Symptom Manage       Date:  2006-06       Impact factor: 3.612

5.  Hospice effect on government expenditures among nursing home residents.

Authors:  Pedro L Gozalo; Susan C Miller; Orna Intrator; Janet P Barber; Vincent Mor
Journal:  Health Serv Res       Date:  2008-02       Impact factor: 3.402

6.  Belgian methodological guidelines for pharmacoeconomic evaluations: toward standardization of drug reimbursement requests.

Authors:  Irina Cleemput; Philippe van Wilder; Michel Huybrechts; France Vrijens
Journal:  Value Health       Date:  2008-11-11       Impact factor: 5.725

Review 7.  The costs of treating terminal patients.

Authors:  Steven Simoens; Betty Kutten; Emmanuel Keirse; Paul Vanden Berghe; Claire Beguin; Marianne Desmedt; Myriam Deveugele; Christian Léonard; Dominique Paulus; Johan Menten
Journal:  J Pain Symptom Manage       Date:  2010-06-25       Impact factor: 3.612

8.  Palliative day care: what does it cost to run a centre and does attendance affect use of other services?

Authors:  H R Douglas; C E Normand; I J Higginson; D M Goodwin; K Myers
Journal:  Palliat Med       Date:  2003-10       Impact factor: 4.762

9.  Home palliative care as a cost-saving alternative: evidence from Catalonia.

Authors:  M Serra-Prat; P Gallo; J M Picaza
Journal:  Palliat Med       Date:  2001-07       Impact factor: 4.762

10.  Cost savings associated with US hospital palliative care consultation programs.

Authors:  R Sean Morrison; Joan D Penrod; J Brian Cassel; Melissa Caust-Ellenbogen; Ann Litke; Lynn Spragens; Diane E Meier
Journal:  Arch Intern Med       Date:  2008-09-08
  10 in total
  1 in total

1.  Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium.

Authors:  C Rinciog; A Diamantopoulos; A Gentilini; B Bondue; C Dahlqvist; A Froidure; W A Wuyts; S Soulard
Journal:  Pharmacoecon Open       Date:  2020-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.